Skip to main content

Davita Healthcare Partners Inc(DVA-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low77.57
Day High78.68
Open:78.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Press & news

Latest News

More Stories
You Won't Believe How Much More Warren Buffett Has Made Than the Market Since 1965
Motley Fool - Tue Mar 14, 5:00AM CDT
Motley Fool
Tue Mar 14, 5:00AM CDT
The trick is waiting long enough to let the magic of compounding do its work.
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
PR Newswire - Mon Mar 13, 2:34PM CDT
PR Newswire
Mon Mar 13, 2:34PM CDT
/PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at...
DaVita (DVA) Q4 2022 Earnings Call Transcript
Motley Fool - Wed Feb 22, 7:00PM CST
Motley Fool
Wed Feb 22, 7:00PM CST
DVA earnings call for the period ending December 31, 2022.

Latest Articles

number cruncher
These 15 U.S. stocks with growing profits also score well on ESG risk
This $100-million fund manager has overseen returns of 19% over the past year. Here’s what he’s buying and selling
opinion
Top stock picks that benefit from Merrill Lynch’s most promising investment theme
Scott Barlow
Scott Barlow
number cruncher
Fifteen North American equities with attractive stock valuations
UnitedHealth plans $2.8B bid to grow South America business
Insurer Humana pushes deeper into delivery of health care
Texas-based DaVita Rx to pay nearly $64M in billing dispute
DaVita and AeroVironment jump while Fred's and Patterson dip
Stock markets subdued as investors focus on US tax, jobs
Separating bargain stock opportunities from potential value traps
Take-Two and Kraft Heinz rise while Snap plunges
inside the market
Calendar: What investors need to know for the week ahead

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.